2017 Merck AR PDF [PDF]

Citation preview

The New



Focus



PT Merck Tbk Laporan Tahunan 2017 2017 Annual Report



The New



Focus The year 2017 marked the Company’s New Focus strategically planned to earn progressive results to boost business growth in the coming years, such as through capacity enhancement, improved consumer services, and employee volunteerism. PT Merck Tbk



2



Laporan Tahunan 2017



Fokus Baru



The New Focus



Kita semua menginginkan kemajuan, dan seringkali, kemajuan terbesar justru terjadi pada saat-saat yang paling kritis. Daya tahan GDQÀHNVLELOLWDVPHUXSDNDQGXDNDUDNWHU penting yang membuat suatu bisnis terus berkembang di pasar yang tengah bergejolak. Sepanjang tahun 2017, PT Merck Tbk telah menunjukkan karakteristik tersebut dan berhasil menjaga momentum untuk terus maju.



We all want progress, and often, the greatest progress comes during the most challenging WLPHV$JLOLW\DQGÀH[LELOLW\GLIIHUHQWLDWHWKRVH businesses that continue to progress in a volatile marketplace, and those that don’t. Throughout 2017, PT Merck Tbk demonstrated those same attributes and more to keep its momentum going.



Bagi Merck, setiap langkah ibarat sebuah tonggak sejarah; dan dalam setiap tonggak sejarah, tertoreh jejak upaya terbaik demi melayani pemangku kepentingan, termasuk pelanggan, karyawan, pemasok, pemegang saham dan masyarakat. Sepanjang tahun 2017, Perseroan mencetak berbagai tonggak sejarah baru yang menunjukkan Fokus Baru untuk meraih tujuan yang lebih tinggi.



For Merck, every new step forward is a milestone, and within each milestone, is the Company’s best efforts in serving our customers, employees, suppliers, shareholders and community. Throughout 2017, the Company reached new milestones that demonstrate its New Focus on achieving higher goals.



Sebagai perusahaan dinamis yang berbasis ilmu pengetahuan dan teknologi dengan dengan riwayat ekspansi bisnis selama 350 tahun, karya-karya Perseroan mendorong perubahan positif bagi jutaan penduduk di Indonesia. Merck memiliki komitmen kuat dalam bisnis healthcare dengan memberikan pelayanan prima kepada pelanggan melalui peningkatan kapasitas, produk dan layanan yang inovatif, serta kontribusi sosial.



As a vibrant science and technology company ±ZLWKD\HDUKLVWRU\RIH[SDQVLRQ±WKH Company makes a difference to millions of lives around Indonesia. Merck serves the growing Indonesian market by its strong focus on the healthcare business and by providing outstanding customer service through capacity enhancement, innovative products and services, as well as social contributions.



PT Merck Tbk



3



2017 Annual Report



Daftar Isi Contents



1



3



IKHTISAR KEGIATAN 2017 2017 HIGHLIGHTS



MANAGEMENT REPORT



40 Laporan Dewan Komisaris Report from the Board of Commissioners  3UR¿O'HZDQ.RPLVDULV  7KH%RDUGRI&RPPLVVLRQHUV¶3UR¿OHV 52 Laporan Direksi Report from the Board of Directors  3UR¿O'LUHNVL  7KH%RDUGRI'LUHFWRUV¶3UR¿OHV



8



Ikhtisar Keuangan Financial Highlights 11 Ikhtisar Saham Stock Highlights 13 Peristiwa Penting Event Highlights  3HQJKDUJDDQ 6HUWL¿NDVL  $ZDUGV &HUWL¿FDWHV



2



LAPORAN MANAJEMEN



TENTANG PERUSAHAAN THE COMPANY AT A GLANCE



24 Data Perusahaan Corporate Data  3UR¿O6LQJNDW  %ULHI3UR¿OH 28 Informasi Pemegang Saham Shareholders Information 31 Visi & Misi Vision & Mission  1LODL1LODL3HUXVDKDDQ Corporate Values 34 Bidang Usaha Business Lines 35 Produk & Layanan Products & Services 36 Struktur Organisasi Organization Structure



4 5



72



DIVISI PLANT PLANT DIVISION



DISKUSI DAN ANALISIS MANAJEMEN



MANAGEMENT DISCUSSION & ANALYSIS



84



Tinjauan Industri Industrial Overview 86 Tinjauan Usaha Business Overview 92 Tinjauan Pemasaran Marketing Overview 99 Tinjauan Keuangan Financial Overview 105 Sumber Daya Manusia Human Resources 112 Prospek Usaha 2018 2018 Business Prospects



PT Merck Tbk



4



Laporan Tahunan 2017



6



TATA KELOLA PERUSAHAAN GOOD CORPORATE GOVERNANCE (GCG)



 .RPLWPHQSDGD3ULQVLS3ULQVLS  7DWD.HOROD Commitment to GCG Principles 117 Rapat Umum Pemegang Saham General Meeting of Shareholders 118 Dewan Komisaris The Board of Commissioners 120 Direksi The Board of Directors 123 Komite Audit Audit Committee  3UR¿O.RPLWH$XGLW  7KH$XGLW&RPPLWWHH¶V3UR¿OH 128 Sekretaris Perusahaan Corporate Secretary  3UR¿O6HNUHWDULV3HUXVDKDDQ  &RUSRUDWH6HFUHWDU\3UR¿OH  $XGLW,QWHUQDO Internal Audit  3UR¿O.HSDOD8QLW,QWHUQDO$XGLW  3UR¿OHRIWKH+HDGRI7KH,QWHUQDO Audit Unit  $XGLW(NVWHUQDO  ([WHUQDO$XGLW 133 Kasus Hukum Legal Cases 133 Manajemen Risiko Risk Management 135 Kode Etik Perusahaan Corporate Code of Conduct  6LVWHP3HODSRUDQ3HODQJJDUDQ Whistleblowing System 138 Akses Informasi Information Access



PT Merck Tbk



5



7 144



146 153 155



TANGGUNG JAWAB PERUSAHAAN CORPORATE RESPONSIBILITY



Komitmen Terhadap Tanggung Jawab Perusahaan Commitment to Corporate Responsibility Kesehatan Healthcare Lingkungan Environment Pemberdayaan Masyarakat Community Empowerment



8 9 2017 Annual Report



160



TANGGUNG JAWAB LAPORAN TAHUNAN



ANNUAL REPORT RESPONSIBILITY



164



LAPORAN KEUANGAN FINANCIAL STATEMENTS



1



IKHTISAR KEGIATAN 2017



2017 HIGHLIGHTS 8



Ikhtisar Keuangan Financial Highlights 11 Ikhtisar Saham Stock Highlights 13 Peristiwa Penting Event Highlights  3HQJKDUJDDQ 6HUWL¿NDVL  $ZDUGV &HUWL¿FDWHV



PT Merck Tbk



6



Laporan Tahunan 2017



PT Merck Tbk



7



2017 Annual Report



IKHTISAR KEGIATAN 2017



IKHTISAR KEUANGAN Financial Highlights



dalam jutaan Rupiah



in million Rupiah



LAPORAN POSISI KEUANGAN



2017



2016



2015



Tahun Fiskal Berakhir 31 Desember



STATEMENT OF FINANCIAL POSITION Fiscal Year Ended December 31



ASET



ASSETS



Piutang



214,743



Persediaan



289,064



231,212



161,125



Inventories



66,082



123,972



150,967



Other Current Assets



569,889



508,615



483,680



7RWDO&XUUHQW$VVHWV



177,729



129,992



110,784



)L[HG$VVHWV



Aset Lancar Lainnya 7RWDO$VHW/DQFDU Aset Tetap



153,431



171,588



Receivables



Aset Tidak Lancar Lainnya



99,388



105,328



47,183



Other Non-Current Assets



7RWDO$VHW7LGDN/DQFDU



277,117



235,320



157,967



7RWDO1RQ&XUUHQW$VVHWV



TOTAL ASET



847,006



743,935



641,647



TOTAL ASSETS



LIABILITAS & EKUITAS



LIABILITIES & EQUITY



/LDELOLWDV



/LDELOLWLHV



Total Liabilitas Jangka Pendek



184,971



Total Liabilitas Jangka Panjang 7RWDO/LDELOLWDV



120,622



132,436



Total Current Liabilities



46,598



40,640



35,668



Total Non-Current Liabilities



231,569



161,262



168,104



7RWDO/LDELOLWLHV



Ekuitas



Equity



Modal Saham



22,400



22,400



22,400



Share Capital



Tambahan Modal Disetor



17,562



17,562



17,562



Additional Paid-In Capital



Saldo Laba



575,475



542,711



433,581



Retained Earnings



7RWDO(NXLWDV



615,437



582,673



473,543



7RWDO(TXLW\



TOTAL LIABILITAS DAN EKUITAS



847,006



743,935



641,647



TOTAL LIABILITIES AND EQUITY



dalam jutaan Rupiah



in million Rupiah



MODAL KERJA & INVESTASI



2017



2016



2015



Tahun Fiskal Berakhir 31 Desember



Fiscal Year Ended December 31



Total Modal Kerja



384,918



387,993



351,244



Total Working Capital



67,667



32,723



41,371



Total Investment



Total Investasi



FREE CASH FLOW (dalam jutaan Rupiah / in million Rupiah)



dalam jutaan Rupiah / in million Rupiah



KEY FIGURES



2017



2016



Change



1,156,648



1,034,807



121,841



208,494



213,297



67,516



18,315



ROS in %



18.0



20.6



ROCE in %



31.5



34.2



Sales 2SHUDWLQJ3UR¿W Free Cash Flow



WORKING CAPITAL & INVESTMENT



2017



67,516



(4,803) 2016



49,201



PT Merck Tbk



2015



8



Laporan Tahunan 2017



18,315 103,180



2017 HIGHLIGHTS Ikhtisar Keuangan | Financial Highlights



dalam jutaan Rupiah



in million Rupiah



LAPORAN LABA RUGI DAN PENGHASILAN KOMPREHENSIF LAIN



2017



2016



2015



Tahun Fiskal Berakhir 31 Desember



STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME Fiscal Year Ended December 31



Penjualan



1,156,648



1,034,807



983,446



Laba Bruto



587,995



542,193



496,256



*URVV3UR¿W



Laba Usaha



208,494



213,297



186,514



2SHUDWLQJ3UR¿W



Laba



144,677



153,843



142,545



3UR¿W



11,288



86



6,274



Other Comprehensive Income



TOTAL PENGHASILAN KOMPREHENSIF



155,965



153,929



148,819



TOTAL COMPREHENSIVE INCOME



RASIO KINERJA KEUANGAN



2017



2016



2015



FINANCIAL PERFORMANCE RATIOS



Penghasilan Komprehensif Lain



Tahun Fiskal Berakhir 31 Desember



Sales



Fiscal Year Ended December 31



Rasio Lancar



3.08



4.22



3.65



Current Ratio



Rasio Cepat



1.52



2.30



2.44



Quick Ratio



Rasio Liabilitas terhadap Ekuitas



0.38



0.28



0.35



Leverage Ratio



Rasio Liabilitas terhadap Total Aset



0.27



0.22



0.26



Liabilities to Total Assets Ratio



11.77



5.22



(16.60)



Change in Sales (%)



1.32



3.43



(17.15)



Change in Comprehensive Income (%)



Rasio Laba terhadap Total Aset (%)



17.08



20.68



22.22



Return on Total Assets (%)



Rasio Laba terhadap Penjualan (%)



12.51



14.87



14.49



Return on Sales (%)



Rasio Laba terhadap Ekuitas (%)



23.51



26.40



30.10



Return on Equity (%)



Perubahan Penjualan (%) Perubahan Penghasilan Komprehensif (%)



PENJUALAN PER SEKTOR BISNIS Sales by Business Sector



2017



99,632



2016



89,905



2015



90,296



Lainnya Others



1,057,016 944,902 893,150



Farmasi Healthcare



PT Merck Tbk



9



2017 Annual Report



2017 HIGHLIGHTS



IKHTISAR SAHAM



Stock Highlights



INFORMASI HARGA SAHAM PERSEROAN SELAMA 2 TAHUN TERAKHIR Share Price Information of the Company for the Last 2 Years JUMLAH SAHAM BEREDAR



448,000,000



NUMBER OF SHARES



(dalam Unit)



(in Unit)



Tahun Year



Periode Period



Tertinggi Highest (Rp.)



Terendah Lowest (Rp.)



Penutupan Closing (Rp.)



-XPODK6DKDP Volume (Unit)



2017



Jan - Mar



9,400



8,800



9,200



210,700



4,121,600,000,000



Apr - Jun



9,600



8,850



9,125



224,100



4,088,000,000,000



Jul - Sep



9,500



8,400



8,700



661,400



3,897,600,000,000



Oct - Dec



8,875



8,350



8,500



122,800



3,808,000,000,000



TOTAL 2017 2016



.DSLWDOLVDVL3DVDU Market Capitalization (Rp.)



1,219,000 Jan - Mar



7,500



6,475



7,100



651,000



3,180,800,000,000



Apr - Jun



10,150



6,900



10,050



710,800



4,502,400,000,000



Jul - Sep



10,250



8,750



9,175



666,100



4,110,400,000,000



Oct - Dec



9,300



8,900



9,200



184,600



4,121,600,000,000



TOTAL 2016



2,212,500



Oct - Dec



Jul - Sep



Apr - Jun



Jan - Mar



1LODL7HUWLQJJL7HUHQGDKGDQ3HQXWXSDQ3HUGDJDQJDQ6DKDP Highest, Lowest and Closing Price of Share’s Trading 2017



High



9,400



8,800



Low



9,200



Close



High



9,600



8,850



Low



9,125



Close



High



9,500



8,400



Low



8,700



Close



8,875



High



8,350



Low



8,500



Close



PT Merck Tbk



11



2017 Annual Report



IKHTISAR KEGIATAN 2017 Ikhtisar Saham | Stock Highlights



KOMPOSISI PEMEGANG SAHAM DAN KEPEMILIKAN SAHAM PER 31 DESEMBER 2017 Composition of Shareholders and Shares Ownership as of December 31, 2017



Pemegang Saham Shareholders



-XPODK3HPHJDQJ6DKDP Number of Shareholders



.HSHPLOLNDQ6DKDP Shares Ownership (unit)



(%)



.HSHPLOLNDQ• 6KDUHµVRZQHUVKLS• - Merck Holding GmbH



1



331,483,000



73.99%



(PHGLD([SRUW&RPSDQ\PE+



1



56,711,920



12.66%



2



388,194,920







- Masyarakat Lainnya/Other Public



840



59,805,080



13.35%



TOTAL



842



448,000,000







.HSHPLOLNDQ Share‘s ownership < 5%



STRUKTUR PEMEGANG SAHAM PERSEROAN PER 31 DESEMBER 2017 The Company‘s Shareholder Structure by Investor as of December 31, 2017 -HQLV3HPRGDO Type of Investor



.HSHPLOLNDQ6DKDP Shares Ownership (unit)



(%)



416,090,720



92.88%



Perorangan Asing / Foreign Individual



4,327,900



0.97%



Institusi Lokal / Local Institution



1,450,080



0.32%



26,131,300



5.83%



448,000,000







Institusi Asing / Foreign Institution



Perorangan Lokal / Local Individual TOTAL



KOMPOSISI PEMEGANG SAHAM & KEPEMILIKAN SAHAM PER 31 DESEMBER 2017 Composition of Shareholders and Ownership as of December 31, 2017



STRUKTUR PEMEGANG SAHAM PER 31 DESEMBER 2017 Shareholders Structure by Investor as of December 31, 2017



13.35%



0.97%



12.66%



0.32% 5.83%



73.99%



92.88%



Merck Holding GmbH (PHGLD([SRUW&RPSDQ\PE+ Masyarakat Lainnya / Other Public



PT Merck Tbk



Institusi Asing / Foreign Institution Perorangan Asing / Foreign Individual Institusi Lokal / Local Institution Perorangan Lokal / Local Individual



12



Laporan Tahunan 2017



2017 HIGHLIGHTS



PERISTIWA PENTING Event Highlights



Sepanjang 2017, Perseroan mengadakan rangkaian kegiatan untuk kampanye pemasaran, tanggung jawab perusahaan, dan sumber daya manusia yang terkait dengan Fokus Baru Perseroan. Throughout 2017, the Company held a series of activities related to marketing campaigns, corporate responsibilities and human resources to emphasize the Company’s New Focus.



PT Merck Tbk



13



2017 Annual Report



IKHTISAR KEGIATAN 2017 Peristiwa Penting | Event Highlights



26 Maret March 26



Bergerak Bersama untuk #LawanNeuropati



15 Maret



Merck dan Perhimpunan Dokter Spesialis Saraf Indonesia (PERDOSSI) bekerjasama



March 15



mengedukasi masyarakat mengenai pentingnya



Media Workshop: Tingkatkan .HVDGDUDQ.DQNHU.RORUHNWDO



saraf tepi dan bagaimana mencegah kerusakan



Merck bersama dengan Yayasan Kanker



#LawanNeuropati”. Kegiatan ini terdiri dari



Indonesia (YKI) dan Perhimpunan Onkologi



seminar edukasi bagi dokter spesialis saraf



Indonesia (POI) mengadakan Media Workshop.



se-Indonesia, fun walk, dan senam NeuroMove



Acara ini bertujuan untuk meningkatkan



yang diikuti lebih dari 5.000 peserta.



saraf tepi melalui tema “Bergerak Bersama



kesadaran kanker kolorektal di kalangan masyarakat dengan mengundang rekan-rekan



Move Together with #LawanNeuropati



media.



Themed as "Move Together with #LawanNeuropati," Merck and the Indonesian



Media Workshop: Improving &RORUHFWDO&DQFHU$ZDUHQHVV



Neurological Association (PERDOSSI)



Merck collaborated with the Indonesian Cancer



to raise awareness on the importance of



Foundation (YKI) and the Indonesian Oncology



peripheral nerves and how to prevent damage



Association (POI) in organizing a Media



to them. The event included educational



:RUNVKRSDWWKH